CORONIS Research S.A.
Evangelia (Lia) Koraki has a wealth of experience in the pharmaceutical industry, currently serving as the President of HACRO and SOP Manager at EUCROF. With a background in Chemistry from the National & Kapodistrian University of Athens, Lia has held various leadership roles such as CEO at CORONIS Research SA and Director of Regulatory Affairs & Clinical Trials at Actelion. Prior to these positions, Lia also held management roles at Pfizer and Parke-Davis.
This person is not in any teams
This person is not in any offices
CORONIS Research S.A.
As a leading CRO for over two decades in Greece and Cyprus, we have been delivering a full spectrum of services to national and international pharmaceutical, biotechnology and medical device industries and other healthcare-related organizations. Our commitment all these years has been to enable our clients carry out their initiatives and successfully accomplish their drug development and market access objectives, through the utility of tailor-made services along with the highest quality standards. Our company is awarded with ISO 9001:2015 Quality Certification, across all company's divisions and functions, and approved by the Greek Competent Authority as a CRO. Being one of the founding members of HACRO (Hellenic Association of CROs) and an active member of EUCROF (European CRO Federation) allow us to be on the front-line of changes and improvements. Driven by our values and mission, we always remain fully committed to our clients’ initiatives. By covering the full spectrum of product development needs, we aim to become one of the most valuable and reliable partners across the whole product’s life-cycle! For more information, visit www.coronis.gr